Back to Los Angeles Capital Management LLC Los Angeles Capital Management LLC

IOVA

17 quarters

Position history for Los Angeles Capital Management LLCLos Angeles Capital Management LLC's holdings in Iovance Biotherapeutics, Inc.

Yes. Los Angeles Capital Management holds 43,186 shares of IOVA (Iovance Biotherapeutics), worth $179,653, as of its Q2 2026 13F filing. It reduced the position by 135,973 shares (-75.9%) from Q1 2026. Los Angeles Capital Management has held IOVA since Q2 2024, across 9 quarterly 13F filings.

Current Value

$179,653

Current Shares

43,186

Total Value Change

-$410,347

Total Shares Change

-18,874

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
43,186
-75.9%
$179,6530.0%$4.16
0
2026-Q1
Increased
179,159
+49.5%
$628,8480.0%$3.51
34
2025-Q4
Increased
119,860
+381.9%
$233,7270.0%$2.73
37
2025-Q3
Decreased
24,871
-34.0%
$53,9700.0%$2.17
0
2025-Q2
Increased
37,655
+127.5%
$64,7670.0%$1.72
34
2025-Q1
Decreased
16,554
-73.2%
$55,1250.0%$3.33
0
2024-Q4
Unchanged
61,759
0.0%
$457,0170.0%$7.40
0
2024-Q3
Increased
61,759
+156.0%
$579,9170.0%$9.39
39
2024-Q2
New
24,124
-
$193,4740.0%$8.02
32
2020-Q4
Exited
0
-100.0%
$00.0%$46.40
0
2020-Q3
Decreased
7,335
-73.9%
$241,0000.0%$32.92
0
2020-Q2
Increased
28,101
+26.3%
$771,0000.0%$27.45
31
2020-Q1
Decreased
22,246
-10.8%
$666,0000.0%$29.94
0
2019-Q4
Unchanged
24,941
0.0%
$690,0000.0%$27.68
0
2019-Q3
Decreased
24,941
-48.4%
$454,0000.0%$18.20
0
2019-Q2
Decreased
48,330
-22.1%
$1.2M0.0%$24.52
0
2019-Q1
New
62,060
-
$590,0000.0%$9.51
34

Other major holders of IOVA: ARK Investment Management LLC, Franklin Templeton Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used